MinervaX announces that the company is a participant in a BMGF grant worth USD 0.5 million.

Awarded to Professor Sharbir Madhi, South Africa for studies on correlates of protection focussing on naturally occurring antibodies directed at the company’s vaccine antigens.

Co.applicatant of the grant is also Professor Bengt Johansson-Lindbom, Lund University, Sweden.